Oncolytics Biotech Inc. (TSE:ONC - Get Free Report)'s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$1.40 and traded as high as C$1.40. Oncolytics Biotech shares last traded at C$1.40, with a volume of 181,909 shares trading hands.
Wall Street Analyst Weigh In
Separately, Raymond James raised Oncolytics Biotech to a "moderate buy" rating in a research note on Thursday, November 14th.
Read Our Latest Report on Oncolytics Biotech
Oncolytics Biotech Trading Up 6.1 %
The company has a current ratio of 4.99, a quick ratio of 8.86 and a debt-to-equity ratio of 6.09. The stock has a market cap of C$107.60 million, a price-to-earnings ratio of -3.68 and a beta of 1.35. The company has a fifty day simple moving average of C$1.38 and a 200-day simple moving average of C$1.40.
About Oncolytics Biotech
(
Get Free Report)
Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.
Read More
Before you consider Oncolytics Biotech, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oncolytics Biotech wasn't on the list.
While Oncolytics Biotech currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
